Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2008
11/27/2008US20080293709 Novel 2-Amino-Heterocycles Useful in the Treatment of Abeta-Related Pathologies
11/27/2008US20080293708 Pyrimidine Derivatives
11/27/2008US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
11/27/2008US20080293668 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/27/2008US20080292626 Kinesin inhibitors
11/27/2008DE102007024470A1 New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis
11/27/2008CA2687944A1 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
11/27/2008CA2687611A1 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
11/27/2008CA2687283A1 Quinazolin-oxime derivatives as hsp90 inhibitors
11/26/2008EP1994413A2 Mass tags for quantitative analyses
11/26/2008EP1994005A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
11/26/2008EP1993612A2 Compositions and methods for treating cognitive disorders
11/26/2008EP1756084B1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1155015B1 Process for the production of tert-butyl (e)-(6-¬2-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl vinyl (4r,6s)-2,2-dimethyl¬1,3 dioxan-4-yl)acetate
11/26/2008CN101312954A 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
11/26/2008CN101311170A Substituted pyrimidine ether compounds and uses thereof
11/26/2008CN100438123C Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such
11/26/2008CN100436450C Novel triarylimidazoles
11/26/2008CN100436429C Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof
11/26/2008CN100436428C Preparation method of rosuvastain and its salt
11/26/2008CN100436427C Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/26/2008CN100436425C Fused imidazolium derivatives
11/26/2008CN100436418C N-Benzyl-3-indenylacetamides derivatives for treating neoplasia
11/25/2008US7456291 Use of a vitamin combination for the treatment of primary headaches
11/25/2008US7456288 Heterocyclic compounds and methods of making and using thereof
11/25/2008US7456281 Nucleic acid melting analysis with saturation dyes
11/25/2008US7456196 Alzheimer's disease; antihistamine; attention deficit disorder; hyperactivity; bipolar disorder; cognition activators; psychological disorder; anticancer agent; antidepressants; antiepileptic agents; gastrointestinal disorder; analgesics; 6-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-2-(3-pyridinyl)quinoline
11/25/2008US7456191 N-Aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
11/25/2008US7456189 For example, (R)-4-(1-Phenylethylamino)-6-[1-(tert-butyloxycarbonyl)piperidin-4-yloxy]-7-methoxy-quinazoline and (R)-4-(1-Phenylethylamino)-6-(piperidin-4-yloxy)-7-methoxyquinazoline dihydrochloride
11/25/2008US7456188 Bone disorders; cardiovascular diseases; hypercholesterolemia; hypertriglyceridemia; vasomotor disorders; urogenital disorders; prostatic hypertrophy; endometrial hyperplasia; cancer and central nervous system disorders, such as, neurodegenerative disorders
11/25/2008US7456185 2-amino-6-phenoxy-substituted quinazoline derivatives; treating arthritis, Crohn's disease, Alzeihmer's disease, adult respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, stroke, sepsis, myocardial infarction, and spondylitis
11/25/2008US7456180 Piperazine derivatives and their use as therapeutic agents
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/20/2008WO2008139894A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same
11/20/2008WO2008109697A3 Ppar active compounds
11/20/2008WO2008054599A3 Rho kinase inhibitors
11/20/2008WO2007109661A3 Methods of preparation and resolution of e/z isomers of vinylfuro[2,3-d] pyrimidine and their biological activities
11/20/2008US20080287667 Nucleic Acid Labeling Compounds
11/20/2008US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
11/20/2008US20080287477 Novel Compounds as Modulators of Ppar
11/20/2008US20080287476 Administration of dipeptidyl peptidase inhibitors
11/20/2008US20080287474 Antiproliferative Pyrimidyl, Fused Pyrimidyl and Pyrimidyl Hydrazones
11/20/2008US20080287473 Novel molecules for regulating cell death
11/20/2008US20080287472 Fungicides
11/20/2008US20080287446 Sulfonyl Containing Compounds as Cysteine Protease Inhibitors
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287410 Pyrimidine derivatives useful as inhibitors of pkc-theta
11/20/2008DE10020061B4 STN-Flüssigkristallmischungen STN liquid crystal mixtures
11/20/2008CA2683941A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
11/20/2008CA2667447A1 Mapk/erk kinase inhibitors
11/19/2008EP1992624A1 Heteroarylamide pyrimidone compounds
11/19/2008EP1992622A1 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
11/19/2008EP1992621A1 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
11/19/2008EP1992620A1 Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases
11/19/2008EP1991533A1 Chemical compounds
11/19/2008EP1991532A2 Compositions and methods for inhibition of the jak pathway
11/19/2008EP1888535B1 New heterocyclylethylbenzamide derivatives
11/19/2008CN101307024A Method for synthesizing 5-nbutyl-2-ethylamido-6-methylpyrimidine-4-dimethyl amine sulfonic acid ester
11/19/2008CN100434425C 4-quinazolone derivative and its use in anti-tumor medicine
11/18/2008US7452995 Aryl aniline β2 adrenergic receptor agonists
11/18/2008US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
11/18/2008US7452911 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/18/2008US7452901 improved pharmacokinetic properties; oral bioavailibility; less side effects; novel intermediates; novel methods for synthesis; help to diagnose cancer/leukemia in vitro; inhibitors of adenosine deaminase; Purine analogues
11/18/2008US7452896 Pyrimidine-sulfamides and their use as endothelian receptor antagonist
11/18/2008US7452895 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2413163C 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides
11/18/2008CA2305802C Amide derivatives or salts thereof
11/18/2008CA2230516C Pyrimidine derivatives
11/13/2008WO2008136754A1 Novel benzyl - 2 -oxo-piperazinyl/ 7-oxo/5-oxa- [1,4] diazepanyl/ 2 -oxo- tetrahydropyrimidinyl derivatives
11/13/2008WO2008136631A1 3,4-dihydroquinazoline derivatives
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008114275A3 Anthranilic acid derivatives as anticancer agents and process for the preparation thereof
11/13/2008WO2008097468A3 Selective endothelin type-a antagonists
11/13/2008WO2008044243A9 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
11/13/2008WO2008028168A3 Serine-threonine protein kinase and parp modulators
11/13/2008US20080281101 Hydroxylation a tetrahydropyran compound, oxidation, coupling to a 2-aminopyrimidine copound; decyclization
11/13/2008US20080280931 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
11/13/2008US20080280930 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors such as tert-butyl 7-[4'-(4''-fluorophenyl)-6'-isopropyl-2'-oxo-3'-methyl-pyrimidin-5'-yl]-(3,5-)dihydroxyl-hept-6-enoate, useful for preventing and treating alzheimer's disease, diabetes, osteoporosis, tumors, cardiovascular and brain disorders
11/13/2008US20080280915 {1-[6-(trifluoromethyl)pyridin-3-yl]methyl}(methyl)- lambda 4-sulfanylidenecyanamide; especially useful for the control of aphids and other sucking insects
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280879 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
11/13/2008US20080280875 Fused phenyl amido heterocyclic compounds
11/13/2008US20080279867 Prevent trabsplant rejection; autoimmune diseases
11/12/2008EP1990338A2 Biphenylcyclopropylamides as p-38 Kinase inhibitors
11/12/2008EP1990337A1 Quinazoline derivatives,preparation methods and uses thereof
11/12/2008EP1644340B1 N-[({'4-substituted piperazine-1-yl}sulfonylmethyl)alkyl]-n-hydroxyformamide compounds as metalloproteinase inhibitors
11/12/2008CN101304990A Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
11/12/2008CN101304979A Quinazoline derivative and pharmaceutical
11/12/2008CN101304978A Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof
11/12/2008CN101304977A Nucleic acid base having perfluoroalkyl group and method for producing the same
11/12/2008CN101302204A Quinazolone compound, composition and application including the same
11/12/2008CN101302203A 6-aryl aminopyrimidine compound and synthetic method thereof
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432059C Quinazolinone derivatives useful as anti-hyperalgesic agents
11/11/2008US7449474 Tri-substituted ureas as cytokine inhibitors
11/11/2008US7449471 5-phenylpyrimidines, their preparation, compositions comprising them and their use
11/11/2008US7449470 Antagonists to treat neurodegenerative diseases like Parkinson's disease; 2,4,6-trisubstituted pyrimidines; N-(2,6-diphenyl-pyrimidin-4-yl)-benzamide
11/11/2008US7449465 glycogen synthase kinase 3 alpha and 3 beta inhibitors; improved phanrmacological activity, potency, selectivity, solubility, permeability, metabolic stability; bipolar disorder; Alzheimer's disease; type II diabetes, neuropathic pain; depression; inflammatory diseases
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 427